Impact Lab acquires 100% of TOMA Advanced Biomedical Assays S.p.A., becoming the largest private enterprise for Genetic Diagnostics in Italy.

 

READ THE PRESS RELEASE

 

We are an international company that provides highly specialized diagnostic services through a coordinated network of units which combine a profound knowledge of pathology with genetic developments. We use the most advanced molecular biology techniques for personalized prevention diagnosis and treatment.